Article preview from "The Pink Sheet" DAILY - March 31, 2009
Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg. Read on...
Article preview from "The Pink Sheet" DAILY - March 31, 2009
The move brings in a key team leader to begin working on the administration's agenda for an agency in crisis, rather than waiting through the potentially lengthy confirmation process.
Sharfstein, who was appointed March 14 by Obama to serve as Principal Deputy Commissioner under Hamburg, does not need to be confirmed by the Senate. He leaves his post as Baltimore's health commissioner behind for FDA's White Oak campus.
To read the rest of this article, purchase it now as a pdf.
